Key points are not available for this paper at this time.
TFRC is significantly increased in pancreatic cancer and is associated with a poor prognosis. Moreover, research on TFRC may generate new ideas for the immunotherapy of pancreatic cancer.
Yang et al. (Wed,) studied this question.